The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Related Posts
Akira Endo, Scholar of Statins That Reduce Heart Disease, Dies at 90
Akira Endo, a Japanese biochemist whose research on fungi helped to lay the groundwork for widely prescribed drugs that lower…
Heat-Related ER Visits Rose in 2023, CDC Study Finds
As record heat enveloped the nation, the rate of emergency room visits increased compared with the previous five years, a…
Your Inhalers and EpiPens Aren’t Very Healthy for the Environment
Single-use insulin pens changed Brian Brandell’s life. Growing up with Type 1 diabetes in the 1970s, he had to carry…